Our Mission: To improve human health and well being through innovative diagnostic tests and global partnerships.
Omega is focused on selling a wide range of specialist products, primarily in the immunoassay, in-vitro diagnostics (IVD) market within three segments: Allergy and Autoimmune, Food Intolerance and Infectious Disease.
Grant of US Patent for Visitect CD4
Omega has been informed by the Burnet Institute that its exclusively licensed CD4 test for monitoring HIVpositive patients has been awarded a US Patent.
Appointment of William E. Rhodes as a Non-Executive Director
Omega announces the appointment of Bill Rhodes as a non-executive director of the Company with effect from 1 May 2013